Literature DB >> 7507125

B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

S Indraccolo1, M Mion, R Zamarchi, A Veronesi, M L Veronese, M Panozzo, C Betterle, A Barelli, A Borri, A Amadori.   

Abstract

B cell dysregulation is a hallmark of human immunodeficiency virus infection. Since B lymphocytes comprise two distinct subpopulations, CD5+ and CD5- cells, we addressed their individual phenotypic and functional behavior. Seropositive patients with both limited and advanced disease progression had an increased percentage of peripheral blood CD5+ B cells, compared to seronegative controls (20.1 +/- 2.1 and 22.7 +/- 5.7, respectively, vs 17.0 +/- 3.4 in controls); however, due to the lymphopenia and reduced number of circulating B cells in infected individuals, the absolute number of CD19+CD5+ lymphocytes was actually reduced. Although HIV-specific antibodies were synthesized spontaneously in vitro only by CD5- B cells, a 10-fold lower degree of spontaneous, non-HIV-specific activation was also displayed by unstimulated CD5+ B cells. These findings indicate that B cell dysregulation during HIV infection involves both the CD5- and the CD5+ B cell compartments; moreover, in view of the putative role of CD5+ B cells in autoimmune phenomena and IL-10 production, these data reinforce the possibility that B cell dysfunction might be causally involved in AIDS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507125     DOI: 10.1007/bf00920013

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  43 in total

Review 1.  B cell activation and HIV infection: protective or potentially detrimental response?

Authors:  A Amadori; L Chieco-Bianchi
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

Review 2.  B-cell activation and HIV-1 infection: deeds and misdeeds.

Authors:  A Amadori; L Chieco-Bianchi
Journal:  Immunol Today       Date:  1990-10

Review 3.  The development and repertoire of B-1 cells (CD5 B cells).

Authors:  A B Kantor
Journal:  Immunol Today       Date:  1991-11

Review 4.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

5.  Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Authors:  J F Krowka; D P Stites; S Jain; K S Steimer; C George-Nascimento; A Gyenes; P J Barr; H Hollander; A R Moss; J M Homsy
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.

Authors:  A Amadori; R Zamarchi; V Ciminale; A Del Mistro; S Siervo; A Alberti; M Colombatti; L Chieco-Bianchi
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

7.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

8.  In vitro infection with HIV enables human CD4+ T cell clones to induce noncognate contact-dependent polyclonal B cell activation.

Authors:  D Macchia; P Parronchi; M P Piccinni; C Simonelli; M Mazzetti; A Ravina; D Milo; E Maggi; S Romagnani
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset.

Authors:  P Casali; S E Burastero; M Nakamura; G Inghirami; A L Notkins
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

10.  Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive.

Authors:  M Nakamura; S E Burastero; A L Notkins; P Casal
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

View more
  4 in total

Review 1.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

3.  The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection.

Authors:  Sophia Steyaert; Lieven Verhoye; Els Beirnaert; Helen Donners; Katrien Fransen; Leo Heyndrickx; Guido Vanham; Geert Leroux-Roels; Peter Vanlandschoot
Journal:  J Immunol Methods       Date:  2007-01-09       Impact factor: 2.303

4.  An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review.

Authors:  S B Zeichner; A Harris; G Turner; M Francavilla; J Lutzky
Journal:  Case Rep Hematol       Date:  2013-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.